Serum Institute of India Obtains Emergency Use Authorisation in India for AstraZeneca ’s COVID-19 Vaccine
6 January 2021 -- AstraZeneca’s COVID-19 vaccine has been granted emergency use authorisation in India as well as Argentina, Dominican Republic, El Salvador, Mexico and Morocco for the active immunisation of adults.
The vaccine was shown...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Argentina Health | AstraZeneca | Clinical Trials | COVID-19 | Dominican Republic Health | El Salvador Health | Emergency Medicine | India Health | Mexico Health | Morocco Health | Pharmaceuticals | Vaccines